Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
targeted tumor treatment
Biotech
Pfizer adds to $65M Parthenon war chest for tumor barrier battle
A new biotech is developing anti-cancer therapies to forge an attack on the protective barrier that shields tumors from the immune system.
Emmy Lucas
Nov 3, 2021 12:00pm
Charles River updates research database, adds new tumor models
Nov 15, 2018 7:41am
Unraveling the mysteries of drug resistance in melanoma
Aug 24, 2018 10:34am
Pionyr Immunotherapeutics gains meaty $62M series B
Dec 13, 2017 8:20am
Amgen pens CytomX I-O pact with major biobucks promise
Oct 4, 2017 7:13am
Abzena licenses PSMA antibodies to Telix
Jul 18, 2017 8:46am
